Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
Ruichen Su, Tian Zhou
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 24

Showing 24 citing articles:

Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidović, Milena Rikalović
Cells (2022) Vol. 11, Iss. 11, pp. 1732-1732
Open Access | Times Cited: 90
Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Hema Kumari Alajangi, Mandeep Kaur, Akanksha Sharma, et al.
Molecular Brain (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 68
Th17 cells and inflammation in neurological disorders: Possible mechanisms of action
Yajun Shi, Bin Wei, Lingjun Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Silvia Squillace, Daniela Salvemini
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 726-739
Open Access | Times Cited: 55
GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 40
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Ruhul Amin, Cristina Quispe, Anca Oana Docea, et al.
Neurochemistry International (2022) Vol. 158, pp. 105376-105376
Closed Access | Times Cited: 39
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression
Shaikh Sheeran Naser, Dibyangshee Singh, Subham Preetam, et al.
Materials Today Bio (2023) Vol. 21, pp. 100701-100701
Open Access | Times Cited: 18
Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases
Citlalli Netzahualcoyotzi, Juan Jair Santillán‐Cigales, Laura Adalid‐Peralta, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 6
Frequencies of Circulating Immune Cells in Patients with Parkinson’s Disease: Correlation with MDS-UPDRS Scores
David Goldeck, Lilly Oettinger, Tamàs Fülöp, et al.
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 2
Open Access
Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
Nianping Zhang, Zhaoli Yan, Xin Hua, et al.
Experimental and Therapeutic Medicine (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Maamoon Saleh, Milica Marković, Katherine E. Olson, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S201-S222
Open Access | Times Cited: 17
Identifying crosstalk genetic biomarkers linking a neurodegenerative disease, Parkinson’s disease, and periodontitis using integrated bioinformatics analyses
Shaonan Hu, Simin Li, Wanchen Ning, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henrı́quez, Mahesh Narayan
Exploration of Neuroprotective Therapy (2023), pp. 207-234
Open Access | Times Cited: 8
Myeloid-specific blockade of notch signaling alleviates dopaminergic neurodegeneration in Parkinson’s disease by dominantly regulating resident microglia activation through NF-κB signaling
Shi-Qian Liang, Penghui Li, Yiyang Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Utilizing Machine Learning to Identify Biomarkers of Endoplasmic Reticulum Stress and Analyze Immune Cell Infiltration in Parkinson’s Disease
Guang Yang, Bing Zhang, Chun Yang Xu, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 8544-8551
Closed Access | Times Cited: 2
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Xiaowei Sun, Rou Gu, Jie Bai
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice
Seon-Young Park, Hyejin Yang, Soyoung Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15237-15237
Open Access | Times Cited: 6
Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner
Wenbin Liu, Meiyang Fan, Wen Lu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
José Miguel Flores-Fernández, Verena Pesch, Aishwarya Sriraman, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access
Alpha-synuclein-specific regulatory T cells ameliorate Parkinson’s disease progression in mice
Hyunsu Bae, Seon‐Young Park, Hyejin Yang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis
Xiaoxia Yang, Zhiyun Wang
Medicine (2023) Vol. 102, Iss. 31, pp. e34456-e34456
Open Access | Times Cited: 1
Alpha-synuclein-specific regulatory T cells ameliorate Parkinson’s disease progression in mice
Seon‐Young Park, Hyejin Yang, Hyemin Go, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Rational design of structure-based vaccines targeting misfolded alpha-synuclein conformers of Parkinson’s disease and related disorders
José Miguel Flores-Fernández, Verena Pesch, Aishwarya Sriraman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top